Interestingly, analysis of the Gepliver database revealed consistent upregulation of DECR1 expression in various liver diseases, including NAFLD, liver cirrhosis, and HCC (Figure S6A). This evidence concerns the gene DECR1 and metabolic dysfunction-associated steatotic liver disease.